3D printing, personalized, paediatric, micro-extrusion, taste masking, Raman mapping

Tabriz, Atabak Ghanizadeh, Nandi, Uttom, Scoutaris, Nicolaos, Sanfo, Karifa, Alexander, Bruce, Gong, Yuchuan, Hui, Ho-Wah, Kumar, Sumit and Douroumis, Dennis ORCID: https://orcid.org/0000-0002-3782-0091 (2022) Personalised paediatric chewable ibuprofen tablets fabricated using 3D micro-extrusion printing technology. International Journal of Pharmaceutics, 626:122135. ISSN 0378-5173 (Print), 1873-3476 (Online) (doi:10.1016/j.ijpharm.2022.122135)

3D printing; oral solid dosage forms; controlled release; isoniazid; rifampicin; tuberculosis

Ghanizadeh Tabriz, Atabak, Nandi, Uttom, Hurt, Andrew, Hui, Ho-Wah, Karki, Shyam, Gong, Yuchuan, Kumar, Sumit and Douroumis, Dionysios ORCID: https://orcid.org/0000-0002-3782-0091 (2020) 3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment. International Journal of Pharmaceutics, 593:120147. ISSN 0378-5173 (doi:10.1016/j.ijpharm.2020.120147)

coronary artery stents, bioresorbable3D printing, virtual testing, drug-coating, structural response

Okereke, Michael I. ORCID: https://orcid.org/0000-0002-2104-012X, Khalaj, Roxanne ORCID: https://orcid.org/0000-0002-9342-5555, Tabriz, Atabak Ghanizadeh, Nandi, Uttom, Scoutaris, Nick and Douroumis, Dennis ORCID: https://orcid.org/0000-0002-3782-0091 (2022) Development of 3D printable bioresorbable drug eluting coronary stents: an experimental and computational investigation. Journal of Drug Delivery Science and Technology, 79:103952. ISSN 1773-2247 (Print), 2588-8943 (Online) (doi:10.1016/j.jddst.2022.103952)

simvastatin, solid dispersions, supercritical carbon dioxide, soluplus polymer, drug dissolution enhancement

Nandi, Uttom, Ajiboye, Adejumoke Lara, Patel, Preksha, Douroumis, Dennis ORCID: https://orcid.org/0000-0002-3782-0091 and Trivedi, Vivek ORCID: https://orcid.org/0000-0001-9304-9214 (2021) Preparation of solid dispersions of simvastatin and soluplus using a single-step organic solvent-free supercritical fluid process for the drug solubility and dissolution rate enhancement. Pharmaceuticals, 14 (9):846. ISSN 1424-8247 (Online) (doi:10.3390/ph14090846)

solid lipid nanoparticles; curcumin; transferrin; prostate cancer; bioconjugation

Akanda, Md Mushfiq, Getti, Giulia ORCID: https://orcid.org/0000-0003-1402-8496, Nandi, Uttom, Mithu, Md Sadeque Hossain and Douroumis, Dionysios ORCID: https://orcid.org/0000-0002-3782-0091 (2021) Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy. International Journal of Pharmaceutics, 599:120416. ISSN 0378-5173 (doi:10.1016/j.ijpharm.2021.120416)

transferrin-conjugated liposomes, sirolimus drug delivery, breast cancer targeting, stealth nanoparticles, in vitro and in vivo evaluation

Nandi, Uttom ORCID: https://orcid.org/0000-0003-1777-3862, Onyesom, Ichioma and Douroumis, Dennis ORCID: https://orcid.org/0000-0002-3782-0091 (2021) Transferrin conjugated stealth liposomes for sirolimus active targeting in breast cancer. Journal of Drug Delivery Science and Technology, 66:102900. ISSN 1773-2247 (Print), 2588-8943 (Online) (doi:10.1016/j.jddst.2021.102900)